According to American Heart Association, about 40 million adults in the U.S. take a statin to lower their cholesterol and reduce the risk for heart disease – and new research suggests that they might also be getting an added anti-cancer benefit.
The study found that those taking statins are less likely to be diagnosed with prostate cancer than people not on statins, and are living comparatively longer after a breast, colorectal, kidney or lung cancer diagnosis. In addition, statins were linked to nearly a 40% reduction in death from colorectal cancer.
Read the full article here.